Nitric oxide donors: chemical activities and biological applications

PG Wang, M Xian, X Tang, X Wu, Z Wen, T Cai… - Chemical …, 2002 - ACS Publications
Nitric Oxide Donors: Chemical Activities and Biological Applications | Chemical Reviews ACS
ACS Publications C&EN CAS Find my institution Log In Chemical Reviews ACS Publications …

Recent developments in nitric oxide donor drugs

MR Miller, IL Megson - British journal of pharmacology, 2007 - Wiley Online Library
During the 1980s, the free radical, nitric oxide (NO), was discovered to be a crucial
signalling molecule, with wide‐ranging functions in the cardiovascular, nervous and immune …

Myeloid derived suppressor cells–a new therapeutic target in the treatment of cancer

R Wesolowski, J Markowitz, WE Carson - Journal for immunotherapy of …, 2013 - Springer
Abstract Myeloid Derived Suppressor Cells (MDSC) are a heterogeneous population of
immature myeloid cells that are increased in states of cancer, inflammation and infection. In …

Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized

JE Weder, CT Dillon, TW Hambley, BJ Kennedy… - Coordination Chemistry …, 2002 - Elsevier
The proposed curative properties of Cu-based non-steroidal anti-inflammatory drugs
(NSAIDs) have led to the development of numerous Cu (II) complexes of NSAIDs with …

Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs

Z Niu, Q Shi, W Zhang, Y Shu, N Yang, B Chen… - Nature …, 2017 - nature.com
Tumor-associated macrophages are increasingly viewed as a target of great relevance in
the tumor microenvironment, because of their important role in cancer progression and …

Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation

LJ Ignarro, GM Buga, LH Wei… - Proceedings of the …, 2001 - National Acad Sciences
The objective of this study was to elucidate the mechanisms by which nitric oxide (NO)
inhibits rat aortic smooth muscle cell (RASMC) proliferation. Two products of the arginine …

The endless saga of monocyte diversity

S Canè, S Ugel, R Trovato, I Marigo… - Frontiers in …, 2019 - frontiersin.org
Cancer immunotherapy relies on either restoring or activating the function of adaptive
immune cells, mainly CD8+ T lymphocytes. Despite impressive clinical success, cancer …

Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination

C De Santo, P Serafini, I Marigo… - Proceedings of the …, 2005 - National Acad Sciences
Active suppression of tumor-specific T lymphocytes can limit the immune-mediated
destruction of cancer cells. Of the various strategies used by tumors to counteract immune …

Microglial activation and β-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus …

PT Jantzen, KE Connor, G DiCarlo… - Journal of …, 2002 - Soc Neuroscience
3-4-(2-Fluoro-α-methyl-[1, 1′-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-
nitrooxy butyl ester (NCX-2216), a nitric oxide (NO)-releasing derivative of the …

Targeting myeloid cells in the tumor sustaining microenvironment

J Schupp, FK Krebs, N Zimmer, E Trzeciak… - Cellular …, 2019 - Elsevier
Myeloid cells are the most abundant cells in the tumor microenvironment (TME). The tumor
recruits and modulates endogenous myeloid cells to tumor-associated macrophages (TAM) …